LEADER 03855nam  2200841z- 450 
001 9910580208803321
005 20231214133411.0
035   $a(CKB)5690000000012000
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/87501
035   $a(EXLCZ)995690000000012000
100   $a20202207d2022      |y             0
101 0 $aeng
135   $aurmn|---annan
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aCholera Control in 2021$eBioecology, Immunology, Current and Future Vaccines and Treatment Options
210   $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022
215   $a1 electronic resource (154 p.)
311   $a3-0365-4239-6 
311   $a3-0365-4240-X 
330   $aCholera remains a global threat in the 21st century, chiefly due to the continued lack of adequate resource provision and the political will to ensure a safe potable water supply and sanitary waste disposal for a burgeoning global population. The current Special Issue on cholera provides an overview of the available control measures from the perspectives of bioecology, immunology and vaccinology and treatment. These modalities have the potential to reduce cholera case fatality rates to less than 1% if properly implemented. In this Special Issue on cholera, the current state of the art in science-based control measures is reported on by several of the world?s leaders in research on the control of cholera and allied acute watery diarrheal diseases. Dr. Rita Colwell, Dr. Anwar Huq and colleagues at the University of Maryland and the University of Florida will review the latest information on environmental factors related to the prediction and prevention of cholera. Dr. Jacqueline Dean and Dr. John Clemens contribute an overview of recent insights into the performance of licensed and recommended cholera vaccines. Dr. Jan Holmgren will present an update on cholera immunity and the next generation of cholera vaccines. Dr. David Nalin will discuss cholera treatment options and optimums for the 21st century, and Dr. Richard A. Cash will focus on bringing diarrhea treatment, control, and prevention to the community.
517   $aCholera Control in 2021 
606   $aPublic health & preventive medicine$2bicssc
610   $aVIP
610   $acholera patients
610   $acholera
610   $aoral cholera vaccine
610   $aefficacy
610   $aeffectiveness
610   $anon-cholera acute watery diarrheas (AWDs)
610   $aoral rehydration solutions (ORS)
610   $aORS formulations
610   $asodium balance
610   $ahyponatremia
610   $ahyponatremic seizures
610   $ahyponatremic sequelae
610   $amucosal immunity
610   $acholera control
610   $adiarrhea
610   $aBurundi
610   $ahot spot
610   $aoral rehydration solution (ORS)
610   $aoral rehydration therapy (ORT)
610   $acommunity-based care
610   $aOTEP
610   $aBRAC
610   $aenvironmental parameters
610   $aVibrio cholerae
610   $atrigger
610   $atransmission
610   $aprediction
610   $aimmunity
610   $ainnate
610   $aadaptive
610   $aantibody
610   $acellular
610   $amucosal
610   $asystemic
610   $amemory
610   $avaccine
610   $anon-cholera dehydrating diarrheas
610   $atranslational medicine
610   $ahistory
610   $aurban health
610   $aoral rehydration
615  7$aPublic health & preventive medicine
700   $aNalin$b David$4edt$01284116
702   $aNalin$b David$4oth
906   $aBOOK
912   $a9910580208803321
996   $aCholera Control in 2021$93019338
997   $aUNINA